Emcure Pharmaceuticals is accelerating domestic expansion while scaling R&D and manufacturing capacity. The company is also scouting acquisition opportunities both in India and abroad, aiming to add new products to fuel growth. A key driver is its partnership with Novo Nordisk for GLP-1 therapies, alongside a pipeline of complex injectables poised to support momentum ahead.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
